- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
A Deadly SOS From Wounded Arteries
14 January 1998 8:30 pm
Like a captain on a sinking ship shooting a flare to call for help, arteries in distress attract immune cells. But instead of rescuing arteries, the immune cells appear to accelerate their decline. The findings, reported in today's issue of the Journal of Clinical Investigation, suggest that putting a damper on part of this distress call may be a new way to treat heart disease.
Everyone knows that "bad" cholesterol tends to build up in arteries and often leads to atherosclerosis. But for a host of other risk factors--such as cigarette smoke and certain bacterial infections--the disease-causing mechanism is unclear. One thing these risk factors have in common, however, is that they trigger an inflammatory and repair response, says Robert Terkeltaub of the Veteran's Administration Hospital in San Diego. It was known that a precursor of macrophages--roving cells deployed by the immune system to consume bacteria and dead cells--speeds up fat deposition in scarred arteries.
Terkeltaub enlisted colleagues at The Scripps Research Institute in La Jolla, California, and the University of California, San Diego, to try to pin down how these precursors, called monocytes, might be attracted to the lesions. Working on mice, Linda Curtiss of Scripps transplanted bone marrow that would churn out white blood cells either with or without the mouse version of CXCR-2, a receptor for chemokines--the distress call put out by wounded cells at the lesion. The team fed both groups of mice an artery-hardening diet: the equivalent of a hamburger a day, Terkeltaub says, "and a milk shake on top of that." After 4 months, the mice with the receptor had arterial lesions 2.5 times the size of lesions in mice without the receptor; the CXCR-2 mice also had significantly higher macrophage counts.
The finding shows that altering the immune response can change the course of atherosclerosis, says Alan Tall of Columbia University. The implication, he says, is that compounds that block chemokine receptors might someday be used in people to protect wounded arteries.